DDW Highlights: 23 January 2023

<p><span data-contrast="auto">The latest episode of the </span><a href= "https://www.ddw-online.com/t/ddw-highlights-podcast/"><span data-contrast="none">DDW Highlights </span><span data-contrast= "none">podcast</span></a><span data-contrast="auto"> is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> Clinical trials have led our news section this week, with positive results announced from several Phase I and II studies. There was good news from Alto Neuroscience, everImmune, Avacta and Abionyx, though unfortunately things are not looking so rosy for Janssen’s HIV vaccine candidate. </span></p>